MONMOUTH JUNCTION, N.J., and AUCKLAND, NEW ZEALAND, January 6, 2009 – MicroDose Technologies Inc. (MicroDose) and Nexus6 today announced that they have entered into a collaboration to investigate the application of Nexus6’s SmartinhalerLive™ technology with MicroDose’s next generation electronic dry powder inhaler (DPI). Under the terms of the agreement, MicroDose will fund the development of prototypes based upon MicroDose’s inhaler platform and incorporating Nexus6’s SmartinhalerLive™ technology. MicroDose will receive an option for an exclusive license to the SmartinhalerLive™ platform for certain fields of use.